- Tao M, Liang F, He J, Ye W, Javed R, Wang W, et al. Decellularized tendon matrix membranes prevent post-surgical tendon adhesion and promote functional repair. Acta Biomater. 2021;134:160-76. doi: 10.1016/j.actbio.2021.07.038. PubMed PMID: 34303866.
- Arjmand MH, Zahedi-Avval F, Barneh F, Mousavi SH, Asgharzadeh F, Hashemzehi M, et al. Intraperitoneal Administration of Telmisartan Prevents Postsurgical Adhesion Band Formation. J Surg Res. 2020;248:171-81. doi: 10.1016/j.jss.2019.10.029. PubMed PMID: 31923833.
- Hu Q, Xia X, Kang X, Song P, Liu Z, Wang M, et al. A review of physiological and cellular mechanisms underlying fibrotic postoperative adhesion. Int J Biol Sci. 2021;17:298-306. doi: 10.7150/ijbs.54403. PubMed PMID: 33390851; PubMed Central PMCID: PMCPMC7757036.
- Soleimani A, Asgharzadeh F, Rahmani F, Avan A, Mehraban S, Fakhraei M, et al. Novel oral transforming growth factor-beta signaling inhibitor potently inhibits postsurgical adhesion band formation. J Cell Physiol. 2020;235:1349-57. doi: 10.1002/jcp.29053. PubMed PMID: 31313829.
- Nichols AEC, Best KT, Loiselle AE. The cellular basis of fibrotic tendon healing: challenges and opportunities. Transl Res. 2019;209:156-68. doi: 10.1016/j.trsl.2019.02.002. PubMed PMID: 30776336; PubMed Central PMCID: PMCPMC6545261.
- Kazemi K, Hosseinzadeh A, Shahriarirad R, Nikeghbalian S, Kamran H, Hosseinpour P, et al. Comparison of Oral Sirolimus, Prednisolone, and Combination of Both in Experimentally Induced Peritoneal Adhesion. J Surg Res. 2022;276:168-73. doi: 10.1016/j.jss.2022.02.047. PubMed PMID: 35344743.
- İnal A, Saydam M. Effect of intraperitoneal and systemic sirolimus administration on postoperative peritoneal adhesions in rats. Journal of Basic and Clinical Health Sciences. 2021;5:195-200. doi: 10.30621/jbachs.977476.
- Chavant A, Fonrose X, Gautier-Veyret E, Hilleret MN, Roustit M, Stanke-Labesque F. Variability of Tacrolimus Trough Concentration in Liver Transplant Patients: Which Role of Inflammation? Pharmaceutics. 2021;13. doi: 10.3390/pharmaceutics13111960. PubMed PMID: 34834375; PubMed Central PMCID: PMCPMC8623792.
- Soubhia RM, Mendes GE, Mendonca FZ, Baptista MA, Cipullo JP, Burdmann EA. Tacrolimus and nonsteroidal anti-inflammatory drugs: an association to be avoided. Am J Nephrol. 2005;25:327-34. doi: 10.1159/000086569. PubMed PMID: 15976495.
- Wen R, editor Comparison of cyclosporin A and tacrolimus in the field of organ transplantation. IOP Conference Series: Earth and Environmental Science; 2020. doi: 10.1088/1755-1315/565/1/012052.
- Su L, Ji J, Bian J, Fu Y, Ge Y, Yuan Z. Tacrolimus (FK506) prevents early retinal neovascularization in streptozotocin-induced diabetic mice. Int Immunopharmacol. 2012;14:606-12. doi: 10.1016/j.intimp.2012.09.010. PubMed PMID: 23032068.
- Vafadari R, Kraaijeveld R, Weimar W, Baan CC. Tacrolimus inhibits NF-kappaB activation in peripheral human T cells. PLoS One. 2013;8:e60784. doi: 10.1371/journal.pone.0060784. PubMed PMID: 23573283; PubMed Central PMCID: PMCPMC3613409.
- Dheer D, Jyoti, Gupta PN, Shankar R. Tacrolimus: An updated review on delivering strategies for multifarious diseases. Eur J Pharm Sci. 2018;114:217-27. doi: 10.1016/j.ejps.2017.12.017. PubMed PMID: 29277665.
- Kim HJ, Lee S, Koo YJ, Kwon E, Kim HJ, Choi JY, et al. Tacrolimus for Treating Orbital and Cranial Form of Idiopathic Inflammatory Pseudotumors. J Clin Neurol. 2020;16:674-80. doi: 10.3988/jcn.2020.16.4.674. PubMed PMID: 33029975; PubMed Central PMCID: PMCPMC7541994.
- Zhang S, Wang H, Liu Y, Yang W, Liu J, Han Y, et al. Tacrolimus ameliorates tubulointerstitial inflammation in diabetic nephropathy via inhibiting the NFATc1/TRPC6 pathway. J Cell Mol Med. 2020;24:9810-24. doi: 10.1111/jcmm.15562. PubMed PMID: 32779844; PubMed Central PMCID: PMCPMC7520323.
- Ren Y, Jian X, Zhang Z, Ning Q, Kan B, Kong L. Effects of tacrolimus on the TGF beta1/SMAD signaling pathway in paraquat exposed rat alveolar type II epithelial cells. Mol Med Rep. 2020;22:3687-94. doi: 10.3892/mmr.2020.11453. PubMed PMID: 33000210; PubMed Central PMCID: PMCPMC7533447.
- Ishiyama N, Moro T, Ohe T, Miura T, Ishihara K, Konno T, et al. Reduction of Peritendinous adhesions by hydrogel containing biocompatible phospholipid polymer MPC for tendon repair. J Bone Joint Surg Am. 2011;93:142-9. doi: 10.2106/JBJS.I.01634. PubMed PMID: 21248211.
- Tang JB, Shi D, Zhang QG. Biomechanical and histologic evaluation of tendon sheath management. J Hand Surg Am. 1996;21:900-8. doi: 10.1016/S0363-5023(96)80212-7. PubMed PMID: 8891993.
- Moran SL, Ryan CK, Orlando GS, Pratt CE, Michalko KB. Effects of 5-fluorouracil on flexor tendon repair. J Hand Surg Am. 2000;25:242-51. doi: 10.1053/jhsu.2000.jhsu25a0242. PubMed PMID: 10722815.
- Muhar AM, Putra A, Warli SM, Munir D. Hypoxia-Mesenchymal Stem Cells Inhibit Intra-Peritoneal Adhesions Formation by Upregulation of the IL-10 Expression. Open Access Maced J Med Sci. 2019;7:3937-43. doi: 10.3889/oamjms.2019.713. PubMed PMID: 32165932; PubMed Central PMCID: PMCPMC7061407.
- Rahmani F, Asgharzadeh F, Avan A, Barneh F, Parizadeh MR, Ferns GA, et al. Rigosertib potently protects against colitis-associated intestinal fibrosis and inflammation by regulating PI3K/AKT and NF-kappaB signaling pathways. Life Sci. 2020;249:117470. doi: 10.1016/j.lfs.2020.117470. PubMed PMID: 32135184.
- Bogacz A, Wolek M, Sienko J, Czerny B, Machalinski B, Olbromski P, et al. Influence of TGFB1 and CTLA4 polymorphisms on calcineurin inhibitors dose and risk of acute rejection in renal transplantation. Sci Rep. 2021;11:17531. doi: 10.1038/s41598-021-96457-7. PubMed PMID: 34475433; PubMed Central PMCID: PMCPMC8413317.
- Siligato R, Cernaro V, Nardi C, De Gregorio F, Gembillo G, Costantino G, et al. Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis. Expert Opin Investig Drugs. 2018;27:839-79. doi: 10.1080/13543784.2018.1540587. PubMed PMID: 30360670.
- Kim CS, Mathew AP, Vasukutty A, Uthaman S, Joo SY, Bae EH, et al. Glycol chitosan-based tacrolimus-loaded nanomicelle therapy ameliorates lupus nephritis. J Nanobiotechnology. 2021;19:109. doi: 10.1186/s12951-021-00857-w. PubMed PMID: 33865397; PubMed Central PMCID: PMCPMC8052756.
- Mailey B, O’Shea G, Romanelli M, West B. Systemic Immunosuppression for Prevention of Recurrent Tendon Adhesions. Plast Reconstr Surg Glob Open. 2021;9:e3834. doi: 10.1097/GOX.0000000000003834. PubMed PMID: 34667696; PubMed Central PMCID: PMCPMC8519255.
- Yan L, Li X, Wang J, Sun Y, Wang D, Gu J, et al. Immunomodulatory effectiveness of tacrolimus in preventing epidural scar adhesion after laminectomy in rat model. Eur J Pharmacol. 2013;699:194-9. doi: 10.1016/j.ejphar.2012.11.037. PubMed PMID: 23220162.
- Ma A, Qi S, Xu D, Ouyang J, Zhang X, Wang Y, et al. Immunological Evaluation of Cytokins, Apoptosis, and Proliferation on Tacrolimus and Sirolimus Induced Long-Term Renal Allograft Survival in Nonhuman Primates. Transplantation. 2004;78:637. doi: 10.1097/00007890-200407271-01715.
- Ma R, Wang Y, Xu Y, Wang R, Wang X, Yu N, et al. Tacrolimus Protects Podocytes from Apoptosis via Downregulation of TRPC6 in Diabetic Nephropathy. J Diabetes Res. 2021;2021:8832114. doi: 10.1155/2021/8832114. PubMed PMID: 34095318; PubMed Central PMCID: PMCPMC8163546.
- Ulug P, Oner G, Sayar I, Nayki U, Nayki C, Peker K. Effects of Immunusuppressive Agents on the Postoperative Adhesion Formation in a Rat Uterine Horn Adhesion Model. International Journal of Academic Research. 2014;6.
- Wu CS, Lan CC, Kuo HY, Chai CY, Chen WT, Chen GS. Differential regulation of nuclear factor-kappa B subunits on epidermal keratinocytes by ultraviolet B and tacrolimus. Kaohsiung J Med Sci. 2012;28:577-85. doi: 10.1016/j.kjms.2012.04.023. PubMed PMID: 23140765; PubMed Central PMCID: PMCPMC11916127.
- Efe C, Taii HA, Ytting H, Aehling N, Bhanji RA, Hagstrom H, et al. Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis. Dig Dis Sci. 2018;63:1348-54. doi: 10.1007/s10620-018-5011-x. PubMed PMID: 29569003.
- Li X, Shang X, Sun L. Tacrolimus reduces atherosclerotic plaque formation in ApoE(-/-) mice by inhibiting NLRP3 inflammatory corpuscles. Exp Ther Med. 2020;19:1393-9. doi: 10.3892/etm.2019.8340. PubMed PMID: 32010314; PubMed Central PMCID: PMCPMC6966157.
|